Changes in weight loss‐related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin

E-ISSN： 1463-1326|16|7|645-650

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.16, Iss.7, 2014-07, pp. : 645-650

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quality of life of patients with diabetes mellitus

By Wändell Per

Scandinavian Journal of Primary Health Care, Vol. 23, Iss. 2, 2005-06 ,pp. : 68-74

Informa Healthcare

Access to resources Recommend Favorite

The cost‐effectiveness of dapagliflozin versus sulfonylurea as an add‐on to metformin in the treatment of Type 2 diabetes mellitus

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 890-898

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of snacks in insulin‐treated people with diabetes mellitus and association with HbA1c, weight and quality of life: a cross sectional study

DIABETIC MEDICINE, Vol. 32, Iss. 3, 2015-03 ,pp. : 353-358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies

By Xie Lin Wei Wenhui Pan Chunshen Baser Onur

Journal of Medical Economics, Vol. 16, Iss. 9, 2013-09 ,pp. : 1137-1145

Informa Healthcare

Access to resources Recommend Favorite